Implementation of the Cass Review resulted in gonadatrophin releasing hormone (GnRH) analogues (puberty blockers) no longer being available to patients under the age of 18 in England and Wales via the National Health Service (NHS).
Share this post
Group seeks Judicial Review of Ban on Private…
Share this post
Implementation of the Cass Review resulted in gonadatrophin releasing hormone (GnRH) analogues (puberty blockers) no longer being available to patients under the age of 18 in England and Wales via the National Health Service (NHS).